30.01.2013 Views

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Poster<br />

Topic: Arthroplasty - Hip<br />

Abstract number: 26365<br />

THE USE OF A METAL ACETABULAR SHELL WITH A PCU LINER FOR TOTAL<br />

HIP RECONSTRUCTION<br />

Jonathan ELSNER 1 , Richard TREHARNE 1 , Emanuele NOCCO 2 , Alex GREENE 2<br />

1 Dept. Orthopaedic Surgery, School of Medicine, University of Tennessee, Memphis<br />

(UNITED STATES), 2 Active Implants Corporation, Memphis (UNITED STATES)<br />

A combination prospective and retrospective review has been performed to gather<br />

clinical data on the use of polycarbonate-urethane (PCU) as an articulating bearing<br />

material inside a cobalt-chrome (Co-Cr) acetabular shell. First implanted in<br />

December 2007, this product has now been used in humans in three countries:<br />

Germany, Spain, and Italy. As of January <strong>2010</strong>, this cobalt-chrome shell and PCU<br />

liner has been implanted into 85 total hip patients by 11 surgeons. A total of 47 were<br />

prospectively followed and 38 retrospectively followed. The indications for use were<br />

in 78 cases of osteoarthritis, 5 cases of femoral neck fracture, 1 case of idiopathic<br />

pathology, and 1 revision case. One patient had an occasional squeak and 1 patient<br />

died of mesenteric ischemia 1 month after surgery. The follow-up times were as<br />

follows: 17 patients at 6 months or less, 47 patients at 12 months, and 21 at 24<br />

months, for an average follow-up time of 14 months. None of the cases has had a<br />

dislocation, revision, dislodgement, or infection. A detailed review of the clinical data<br />

of these patients shows that PCU liner inserted into a Co-Cr acetabular shell is as<br />

safe and effective as other commonly used acetabular shells in other total hip<br />

systems currently available. No new or unintended adverse or device related events<br />

were discovered with the clinical use of PCU in a Co-Cr acetabular shell.<br />

110

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!